Conduite à tenir chez les femmes ayant une prédisposition héréditaire au cancer du sein : DEPISTAGE ET DIAGNOSTIC PRECOCE DES CANCERS = Management of women with inherited predisposition to breast cancer : MASS SCREENING AND EARLY DIAGNOSIS OF CANCERSNOGUES, Catherine.La Revue du praticien (Paris). 2010, Vol 60, Num 2, pp 194-195, issn 0035-2640, 2 p.Article

Les seconds cancers après cancer du sein = Second cancers after breast cancerNOGUES, Catherine.La Lettre du sénologue. 2000, Num 11, pp 36-37, issn 1289-2505Article

Indications et efficacité de la chirurgie prophylactique des cancers gynécologiques et digestifs avec prédisposition génétique = Prophylactic surgery in common hereditary cancer syndromesNOGUES, Catherine; MOURET-FOURME, Emmanuelle.Bulletin de l'Académie nationale de médecine. 2012, Vol 196, Num 7, pp 1237-1245, issn 0001-4079, 9 p.Article

Consultation d'oncogénétique pour le cancer du sein : Cancer du sein : Une incidence en forte augmentation mais de réels progrès thérapeutiques = Oncogenetic consultation for breast cancerCHOMPRET, Agnès; NOGUES, Catherine; STOPPA-LYONNET, Dominique et al.La Presse médicale (1983). 2007, Vol 36, Num 2, pp 357-363, issn 0755-4982, 7 p., CAH2Article

Avoir un enfant et accéder au DPN/DPI pour des femmes porteuses d'une mutation BRCA ? Malades et indemnes appréhendent la question différemment = Having a child and PND/PGD access in women with a BRCA1/2. mutation? Different approach whether ill or healthyPELLEGRINI, Isabelle; PRODROMOU, Niki; COUPIER, Isabelle et al.Bulletin du cancer. 2014, Vol 101, Num 11, pp 1001-1008, issn 0007-4551, 8 p.Article

Cancer risk management strategies and perceptions of unaffected women 5 years after predictive genetic testing for B RCA1/2 mutationsJULIAN-REYNIER, Claire; MANCINI, Julien; MOURET-FOURME, Emmanuelle et al.European journal of human genetics. 2011, Vol 19, Num 5, pp 500-506, issn 1018-4813, 7 p.Article

Impact of an information booklet on satisfaction and decision-making about BRCA genetic testingMANCINI, Julien; NOGUES, Catherine; LASSET, Christine et al.European journal of cancer (1990). 2006, Vol 42, Num 7, pp 871-881, issn 0959-8049, 11 p.Article

Breast and ovarian cancer screening of non-carriers from BRCA1/2 mutation-positive families: 2-year follow-up of cohorts from France and QuebecDORVAL, Michel; NOGUES, Catherine; BERTHET, Pascaline et al.European journal of human genetics. 2011, Vol 19, Num 5, pp 494-499, issn 1018-4813, 6 p.Article

Variation in breast cancer risk with mutation position, smoking, alcohol, and chest X-ray history, in the French National BRCA1/2 carrier cohort (GENEPSO)LECARPENTIER, Julie; NOGUES, Catherine; GESTA, Paul et al.Breast cancer research and treatment. 2011, Vol 130, Num 3, pp 927-938, issn 0167-6806, 12 p.Article

Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study : A report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS collaborating groupBROHET, Richard M; GOLDGAR, David E; NOGUES, Catherine et al.Journal of clinical oncology. 2007, Vol 25, Num 25, pp 3831-3836, issn 0732-183X, 6 p.Article

Life-threatening sepsis associated with adjuvant doxorubicin plus docetaxel for intermediate-risk breast cancerBRAIN, Etienne G. C; BACHELOT, Thomas; ROUËSSE, Jacques et al.JAMA, the journal of the American Medical Association. 2005, Vol 293, Num 19, pp 2367-2371, issn 0098-7484, 5 p.Article

Development of a scale for assessing respondents' perceptions of health research questionnaires (the REP-HQ Scale)BOUHNIK, Anne-Déborah; FABRE, Roxane; DORVAL, Michel et al.Journal of clinical epidemiology. 2012, Vol 65, Num 10, pp 1098-1106, issn 0895-4356, 9 p.Article

Cancer Risks Associated With Germline Mutations in MLH1, MSH2, and MSH6 Genes in Lynch SyndromeBONADONA, Valérie; BONAITI, Bernard; COLAS, Chrystelle et al.JAMA, the journal of the American Medical Association. 2011, Vol 305, Num 22, pp 2304-2310, issn 0098-7484, 7 p.Article

Pregnancies, breast-feeding, and breast cancer risk in the international BRCA1/2 carrier cohort study (IBCCS)ANDRIEU, Nadine; GOLDGAR, David E; NOGUES, Catherine et al.Journal of the National Cancer Institute. 2006, Vol 98, Num 8, pp 535-544, issn 0027-8874, 10 p.Article

Breast cancer risk in BRCA1 and BRCA2 mutation carriers and polyglutamine repeat length in the AIB1 geneHUGHES, David J; GINOLHAC, Sophie M; GIRAUD, Sophie et al.International journal of cancer. 2005, Vol 117, Num 2, pp 230-233, issn 0020-7136, 4 p.Article

BRCA1 wild-type allele modifies risk of ovarian cancer in carriers of BRCA1 germ-line mutationsGINOLHAC, Sophie M; GAD, Sophie; MULLER, Danièle et al.Cancer epidemiology, biomarkers & prevention. 2003, Vol 12, Num 2, pp 90-95, issn 1055-9965, 6 p.Article

Le syndrome de Li-Fraumeni : mise au point, données nouvelles et recommandations pour la prise en charge = Li-Fraumeni's syndrome: up-to-date and management guidelinesFREBOURG, Thierry; ABEL, Anne; FEINGOLD, Josué et al.MTP. Médecine thérapeutique pédiatrie. 2001, Vol 4, Num 1, pp 35-40, issn 1286-5494Article

Professionals Assess the Acceptability of Preimplantation Genetic Diagnosis and Prenatal Diagnosis for Managing Inherited Predisposition to CancerJULIAN-REYNIER, Claire; CHABAL, Françoise; FREBOURG, Thierry et al.Journal of clinical oncology. 2009, Vol 27, Num 27, pp 4475-4480, issn 0732-183X, 6 p.Article

Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study : A report from the EMRACE, GENEPSO, GEO-HEBON, and IBCCS collaborators' groupBRADBURY, Angela; OLOPADE, Olufumilayo I; SIMARD, Jacques et al.Journal of clinical oncology. 2006, Vol 24, Num 21, issn 0732-183X, 3328-3330,3361-3366 [9 p.]Article

Common BRCA2 variants and modification of breast and ovarian cancer risk in BRCA1 mutation carriersHUGHES, David J; GINOLHAC, Sophie M; HARDOUIN, Agnès et al.Cancer epidemiology, biomarkers & prevention. 2005, Vol 14, Num 1, pp 265-267, issn 1055-9965, 3 p.Article

Identification et prise en charge des prédispositions héréditaires aux cancers du sein et de l'ovaire (mise à jour 2004) = Identification and management of hereditary breast/ovarian cancers (2004 update)EISINGER, Francois; BRESSAC, Brigitte; SOBOL, Hagay et al.Bulletin du cancer. 2004, Vol 91, Num 3, pp 219-237, issn 0007-4551, 19 p.Article

Le syndrome de Li-Fraumeni: mise au point, données nouvelles et recommandations pour la prise en charge = Li-Fraumeni syndrome : update, new data and guidelines for clinical managementFREBOURG, Thierry; ABEL, Anne; FEINGOLD, Josué et al.Bulletin du cancer. 2001, Vol 88, Num 6, pp 581-587, issn 0007-4551Article

Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation CarriersPHILLIPS, Kelly-Anne; MILNE, Roger L; BUYS, Saundra S et al.Journal of clinical oncology. 2013, Vol 31, Num 25, pp 3091-3099, issn 0732-183X, 9 p.Article

Spontaneous disclosure of BRCA112 genetic test results to employers: a French prospective studyEISINGER, François; FABRE, Roxane; LASSET, Christine et al.European journal of human genetics. 2012, Vol 20, Num 9, pp 981-983, issn 1018-4813, 3 p.Article

Reproductive and Hormonal Factors, and Ovarian Cancer Risk for BRCA1 and BRCA2 Mutation Carriers : Results from the International BRCA1/2 Carrier Cohort StudyANTONIOU, Antonis C; ROOKUS, Matti; FAIVRE, Laurence et al.Cancer epidemiology, biomarkers & prevention. 2009, Vol 18, Num 2, pp 601-610, issn 1055-9965, 10 p.Article